Biogen officially opened its new, five-story tall 190,000 square foot building in RTP last week.
The facility helps the company consolidate its Triangle employees in one location.
Biogen (Nasdaq: BIIB) broke ground for the facility in April 2011.
“With the opening of this beautiful facility Biogen Idec has united on one site more than 1,000 people dedicated to meeting the needs of patients with serious diseases,” said George Scangos, Biogen’s chief executive officer, at the dedication on Thursday. “The expansion of our footprint in RTP underscores our commitment to providing a secure supply of medicines and to helping patients overcome obstacles to receiving them.”
Biogen manufactures two multiple sclerosis drugs and other products at its RTP campus.
“Our RTP site focuses on patient care – from manufacturing high quality therapies to providing patient support and financial assistance. With this new building, our employees are constantly reminded of our purpose through the patient stories that adorn the main areas and workspaces within the building,” said Machelle Sanders, vice president for manufacturing and general manager for Biogen in RTP.
North Carolina is home to the nation’s third largest biotechnology and life science cluster, most of which is based in RTP.
